Zura Bio Highlights TibuSURE Phase 2 Trial Design
at www.tipranks.com (Thu, 5-Mar 7:42 AM)
Market Chameleon (Wed, 25-Feb 11:21 AM)
Zura Bio’s $125 Million Public Offering Highlights Strategic Growth in Autoimmune Pipeline
Market Chameleon (Wed, 25-Feb 7:32 AM)